Fig. 1From: Antithrombotic drug removal with hemoadsorption during off-pump coronary artery bypass graftingHemoadsorption device (CytoSorb® 300, CytoSorbents Inc., Princeton, NJ, USA) incorporated in the apheresis machine PUR-01 (Nikkisio Co., Ltd., Tokyo, Japan)Back to article page